CLINICAL_TRIALS
research
· 2025-05-14
Clinical Trial Update: A Study to Assess the Effects of Dexpramipexole in Participants With Eosinophilic COPD [Phase 2]
Summary
Phase 2 trial evaluating dexpramipexole in eosinophilic COPD; current status is active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Areteia Therapeutics | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING